Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.64 |
| ▸ | CA1 | P00915 | 3/20 | 0.64 |
| ▸ | CA2 | P00918 | 3/20 | 0.64 |
| ▸ | CA7 | P43166 | 3/20 | 0.64 |
| ▸ | CA9 | Q16790 | 3/20 | 0.64 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | HPGD | P15428 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.59 |
| ▸ | G6PD | P11413 | 1/20 | 0.53 |
| ▸ | CASP7 | P55210 | 1/20 | 0.53 |
| ▸ | CASP6 | P55212 | 1/20 | 0.53 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | CA6 | P23280 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL28098266 | 0.98 | CA12 (0.61) | CA12CA1CA2CA7CA9 | |
| SCHEMBL698805 | 0.87 | KDM4E (0.64) | CA12CA1CA2CA7CA9 | |
| SCHEMBL8844181 | 0.87 | ALDH1A1 (0.50) | CA12CA1CA2CA7CA9 | |
| SCHEMBL318601 | 0.85 | CA12 (0.73) | CA12CA1CA2CA7CA9 | |
| SCHEMBL29804640 | 0.85 | CA12 (0.73) | CA12CA1CA2CA7CA9 | |
| SCHEMBL2343686 | 0.83 | G6PD (0.59) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1650143 | 0.83 | CA12 (0.70) | CA12CA1CA2CA7CA9 | |
| SCHEMBL462218 | 0.83 | ALDH1A1 (0.50) | CA12CA1CA2CA7CA9 | |
| SCHEMBL27650782 | 0.83 | CA12 (0.70) | CA12CA1CA2CA7CA9 | |
| SCHEMBL28555266 | 0.83 | CA12 (0.70) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7572459-B2 | Prevention infections in humans, animals | STARPHARMA PTY LTD. (AU) | 2009-08-11 | — | — | US | claimed |
| US-20090181302-A1 | ELECTROLYTE ADDITIVE FOR PERFORMANCE STABILITY OF BATTERIES | MEDTRONIC, INC. (US) | 2009-07-16 | — | — | US | claimed |
| US-20030129158-A1 | Anionic or cationic dendrimer antimicrobial or antiparasitic compositions | STARPHARMA LIMITED | 2003-07-10 | — | — | US | claimed |
| CN-122072262-A | Detection method and kit for absolute quantification of multiple neurotransmitters and related metabolites | 清华大学 | 2026-05-22 | — | — | CN | disclosed |
| CN-120195409-A | Composition for diagnosing sepsis and medicament for sepsis preventive treatment | 北京大学第三医院（北京大学第三临床医学院） | 2025-06-24 | — | — | CN | disclosed |
| CN-120058621-A | 2, 3-Dihydro quinazoline derivative containing substituted phenyl, preparation method and application thereof | 中国医学科学院药物研究所 | 2025-05-30 | — | — | CN | disclosed |
| CN-118566488-A | Reagent combination for detecting depression, manufacturing method, detection system and application thereof | 合肥歆智医疗器械有限公司 | 2024-08-30 | — | — | CN | disclosed |
| CN-118226044-A | Depression detection reagent combination capable of judging type, detection system and application | 合肥歆智医疗器械有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-115124485-B | Sulfoxide-containing benzoxazole derivative, and preparation method and application thereof | 中国医学科学院药物研究所 | 2023-12-15 | — | — | CN | disclosed |
| CN-115998744-A | Application of pivalamide compound in preparation of medicines for treating ischemic cerebral apoplexy and IDO1 enzyme inhibitor | 南京鼓楼医院 | 2023-04-25 | — | — | CN | disclosed |
| CN-109293468-A | A method of it being catalyzed the decarboxylation coupling reaction synthesizing cis alkene of NHP ester and terminal aryl group alkynes by iridium | 中南大学 | 2019-02-01 | — | — | CN | disclosed |
| CN-101500603-A | Adjuvant-sparing multi-dose influenza vaccination regimen | NOVARTIS AG (CH) | 2009-08-05 | — | — | CN | disclosed |
| CN-101370515-A | Influenza vaccines comprising a combination of particulate adjuvants and immunopotentiators | NOVARTIS VACCINES & DIAGNOSTIC (IT) | 2009-02-18 | — | — | CN | disclosed |
| CN-101365483-A | Adjuvanted influenza vaccines comprising cytokine inducers | NOVARTIS VACCINES & DIAGNOSTIC (IT) | 2009-02-11 | — | — | CN | disclosed |
| CN-101365485-A | Emulsions with free aqueous-phase surfactant as adjuvants for split influenza vaccines | NOVARTIS VACCINES & DIAGNOSTIC (IT) | 2009-02-11 | — | — | CN | disclosed |
| CN-101346152-A | Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture | NOVARTIS VACCINES & DIAGNOSTIC (IT) | 2009-01-14 | — | — | CN | disclosed |
| CN-101325967-A | Influenza vaccines with reduced adjuvant content of oil-in-water emulsions | NOVARTIS VACCINES & DIAGNOSTIC (IT) | 2008-12-17 | — | — | CN | disclosed |
| US-20030129158-A1 | Anionic or cationic dendrimer antimicrobial or antiparasitic compositions | STARPHARMA LIMITED | 2003-07-10 | — | — | US | disclosed |
| CN-1034331-C | Amines and their use | MITSUI PHARMACEUTICALS LTD (JP) | 1997-03-26 | — | — | CN | disclosed |
| EP-0171707-A2 | Process for the fabrication of polyimide-esters of trimellitic acid | BAYER AG (DE) | 1986-02-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030129158-A1 | Anionic or cationic dendrimer antimicrobial or antiparasitic compositions | FUT6, B3GNT2, SIGLEC7 | CA12 960/4885CA1 2006/4885CA2 1974/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.